Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Downgrades CytomX Therapeutics to Market Perform

Cowen & Co. Downgrades CytomX Therapeutics to Market Perform

Cowen & Co. analyst Boris Peaker downgrades CytomX Therapeutics (NASDAQ:CTMX) from Outperform to Market Perform.

byBenzinga Newsdesk

July 11, 2022

1 minute read

Cowen & Co. analyst Boris Peaker downgrades CytomX Therapeutics (NASDAQ:CTMX) from Outperform to Market Perform.

Related Posts

Read More

Goldman Sachs Maintains Neutral on Newmark Group, Lowers Price Target to $10.25

By Benzinga Newsdesk

October 19, 11:06 AM

Goldman Sachs analyst Chandni Luthra maintains Newmark Group (NASDAQ:NMRK) with a Neutral and lowers the price target from $13.25 to $10.25.

Read More

Ethereum Tops This Key Level; Axie Infinity Emerges As Top Gainer

October 30, 9:36 AM

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the $34,600 level on Monday. Ethereum (CRYPTO: ETH) also recorded gains, trading above the key $1,800 mark this morning.

Read More

News

Uber Partners With Office Depot To Deliver Office And School Supplies Nationwide

By Benzinga Newsdesk

August 15, 9:02 AM

Today Uber Technologies, Inc. (NYSE:UBER) and Office Depot, a wholly owned subsidiary of The ODP Corporation (NASDAQ:ODP) and leading provider of business services and supplies, products and technology solutions,

Read More

AMC CEO Adam Aron Tweets: Our new AMC Preferred Equity starts trading on August 22 on the New York Stock Exchange, symbol is APE…

By Charles Gross

August 12, 5:42 AM

https://twitter.com/CEOAdam/status/1558025134014730240